title: [A multi-center clinical trial of Qianlieantong tablets for chronic prostatitis].
abstract: OBJECTIVE
  To observe the efficacy and safety of Qianlieantong Tablets in the treatment of chronic prostatitis.
  
  
  METHODS
  A multi-center, self-controlled open clinical trial was conducted. A total of 280 subjects with chronic prostatitis were enrolled and treated by Qianlieantong Tablets, 3 times a day, 5 tablets each time. Before and after 2 and 4 weeks after the administration, NIH-CPSI scores and white blood cell counts in the prostate secretion were recorded.
  
  
  RESULTS
  Of the 273 subjects evaluated, the rates of excellence, effectiveness and ineffectiveness were 35.2% (n = 96), 47.6% (n = 130) and 17.2% (n = 47), respectively, with a total effectiveness rate of 82.8%. After 4 weeks'medication, the scores of the subjects on NIH-CPSI pain, voiding and quality of life and white blood cell counts in prostate secretion were significantly decreased compared with pre-treatment (P < 0.01). No adverse events or laboratory abnormality related to the medication were observed.
  
  
  CONCLUSIONS
  Qianlieantong Tablets has a significant effect on chronic prostatitis with high safety, particularly indicated in chronic prostatitis with pelvic pain.
authors.affiliation: Department of Urology, Peopleś Hospital of Sichuan Province, Chengdu, Sichuan 610072, China. yiqiao@163.com
authors.forename: Kai
authors.initials: K
authors.lastname: Guo
authors.forename: Ming-Xing
authors.initials: MX
authors.lastname: Qiu
authors.forename: Song-Liang
authors.initials: SL
authors.lastname: Cai
authors.forename: Jing
authors.initials: J
authors.lastname: Leng
authors.forename: Yin-Fa
authors.initials: YF
authors.lastname: Han
authors.forename: Guo-Xing
authors.initials: GX
authors.lastname: Shao
authors.forename: Chuan-Hang
authors.initials: CH
authors.lastname: Wang
authors.forename: Xiang-An
authors.initials: XA
authors.lastname: Tu
authors.forename: Luo-Yan
authors.initials: LY
authors.lastname: Yang
authors.forename: Ge-Ming
authors.initials: GM
authors.lastname: Chen
authors.forename: Qiang
authors.initials: Q
authors.lastname: Zhou
authors.forename: Yong
authors.initials: Y
authors.lastname: Deng
authors.forename: Xiao-Long
authors.initials: XL
authors.lastname: Wang
mesh_terms: D000328:Adult; D002908:Chronic Disease; D004334:Drug Administration Schedule; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008516:Medicine, Chinese Traditional; D008875:Middle Aged; D011472:Prostatitis / Q000188:drug therapy*; D011788:Quality of Life; D013607:Tablets; D016896:Treatment Outcome
chemical_list: D004365:Drugs, Chinese Herbal; D013607:Tablets; C532631:qianlieantong